Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors
08 déc. 2022 16h30 HE
|
Certara
PRINCETON, N.J., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and...
Certara Reports Third Quarter 2022 Financial Results
07 nov. 2022 16h15 HE
|
Certara
PRINCETON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the third quarter of fiscal year 2022 and...
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
07 nov. 2022 08h00 HE
|
Certara
PRINCETON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and...
Certara to Participate in Upcoming Investor Conferences
02 nov. 2022 17h00 HE
|
Certara
PRINCETON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions
19 oct. 2022 08h00 HE
|
Certara
PRINCETON, N.J., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Certara, Inc., (Nasdaq: CERT) a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA)...
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
13 oct. 2022 07h45 HE
|
Certara
PRINCETON, N.J., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of...
Certara to Participate in Upcoming Investor Conferences
31 août 2022 08h00 HE
|
Certara
PRINCETON, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...
Certara Announces Secondary Offering
11 août 2022 16h38 HE
|
Certara
PRINCETON, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) (“Certara”), a global leader in biosimulation, today announced the sale by certain stockholders (the “Selling...
Certara Reports Second Quarter 2022 Financial Results
09 août 2022 16h15 HE
|
Certara
PRINCETON, N.J., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the second quarter of fiscal year 2022 and...
Certara推出Pinnacle 21™ Enterprise更新和全新的Pinnacle 21™ Data Exchange 模块
09 août 2022 00h48 HE
|
Certara USA, Inc.
新泽西州普林斯顿, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Certara, Inc.(纳斯达克股票代码：CERT)为全球生物模拟领域的领军企业，今日宣布发布Pinnacle 21 Enterprise 5.2.0版，这款软件是公司的旗舰软件，用于验证进行生物模拟和向监管机构递交材料所需的临床试验数据。Certara还推出了全新的Pinnacle 21 Data...